Nkarta (NKTX) Shares Outstanding (Weighted Average) (2019 - 2026)

Nkarta's quarterly Shares Outstanding (Weighted Average) came in at $74.3 million in Q1 2026, little changed year-on-year from $73.9 million in Q1 2025, and up 4.6% quarter-over-quarter from $71.0 million in Q4 2025.

Nkarta has reported Shares Outstanding (Weighted Average) for 8 years, with the latest figure at $74.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.46% year-over-year to $74.3 million; the trailing twelve-month figure through Mar 2026 stood at $74.3 million (changed 0.46% YoY), and the FY2025 full-year result was $71.0 million, up 4.61% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $74.3 million, up from $71.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $74.3 million in Q1 2026, with the low at $3.0 million in Q1 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $54.7 million, with a median of $49.0 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Weighted Average) sank 93.87% in 2024 and surged 2363.86% in 2025.
  • Tracing NKTX's Shares Outstanding (Weighted Average) over 5 years: stood at $43.6 million in 2022, then gained by 12.34% to $49.0 million in 2023, then jumped by 38.46% to $67.9 million in 2024, then grew by 4.61% to $71.0 million in 2025, then increased by 4.6% to $74.3 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $74.3 million (Q1 2026), $71.0 million (Q4 2025), and $71.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 177,333.76 Bn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 185,491.37 Bn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 55.66 Bn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 132.89 Mn
10 Nkarta 232.80 Mn 232.80 Mn - 74.26 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 74.26 Mn
Dec 31, 2025 70.99 Mn
Sep 30, 2025 70.97 Mn
Jun 30, 2025 73.95 Mn
Mar 31, 2025 73.92 Mn
Dec 31, 2024 67.87 Mn
Sep 30, 2024 63.88 Mn
Jun 30, 2024 73.49 Mn
Mar 31, 2024 3.00 Mn
Dec 31, 2023 49.01 Mn
Sep 30, 2023 48.99 Mn
Jun 30, 2023 48.95 Mn
Mar 31, 2023 48.92 Mn
Dec 31, 2022 43.63 Mn
Sep 30, 2022 41.88 Mn
Jun 30, 2022 43.84 Mn
Mar 31, 2022 33.00 Mn
Dec 31, 2021 32.86 Mn
Sep 30, 2021 32.90 Mn
Jun 30, 2021 32.84 Mn
Mar 31, 2021 32.74 Mn
Dec 31, 2020 16.92 Mn
Sep 30, 2020 11.62 Mn
Jun 30, 2020 1.78 Mn
Mar 31, 2020 1.61 Mn
Dec 31, 2019 1.71 Mn
Sep 30, 2019 1.42 Mn
Jun 30, 2019 1.70 Mn